当前位置:首页 - 行情中心 - 康华生物(300841) - 财务分析 - 现金流量表

康华生物

(300841)

  

流通市值:67.88亿  总市值:74.17亿
流通股本:1.19亿   总股本:1.30亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金233,324,058.561,280,378,702.88863,856,151.93526,814,912.41
  收到的税费返还--66,30066,300
  收到其他与经营活动有关的现金23,056,630.5416,842,191.3510,429,261.136,343,830.74
  经营活动现金流入小计256,380,689.11,297,220,894.23874,351,713.06533,225,043.15
  购买商品、接受劳务支付的现金4,836,327.1333,407,620.4528,640,735.2618,146,079.17
  支付给职工以及为职工支付的现金52,353,563.73152,471,745.48127,322,820.2493,551,440.65
  支付的各项税费29,478,284.1471,753,965.4654,708,308.7434,243,166.69
  支付其他与经营活动有关的现金148,839,837.28659,877,277.8509,954,643.94321,961,868.92
  经营活动现金流出小计235,508,012.28917,510,609.19720,626,508.18467,902,555.43
  经营活动产生的现金流量净额20,872,676.82379,710,285.04153,725,204.8865,322,487.72
二、投资活动产生的现金流量:
  收回投资收到的现金451,000,0001,018,315,350.17515,768,711.84260,000,000
  取得投资收益收到的现金1,172,423.219,749,660.654,602,005116,367.66
  处置固定资产、无形资产和其他长期资产收回的现金净额-67,869.4617,50017,500
  投资活动现金流入小计452,172,423.211,028,132,880.28520,388,216.84260,133,867.66
  购建固定资产、无形资产和其他长期资产支付的现金8,568,041.2270,785,928.948,071,836.0733,586,357.51
  投资支付的现金992,000,000810,000,000560,000,000310,000,000
  投资活动现金流出小计1,000,568,041.22880,785,928.9608,071,836.07343,586,357.51
  投资活动产生的现金流量净额-548,395,618.01147,346,951.38-87,683,619.23-83,452,489.85
三、筹资活动产生的现金流量:
  取得借款收到的现金-179,793,800149,793,800139,793,800
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-179,793,800149,793,800139,793,800
  偿还债务支付的现金109,793,800226,784,905.68186,784,905.68175,344,705.68
  分配股利、利润或偿付利息支付的现金393,940.04136,430,355.71135,686,621.95134,881,273.3
  筹资活动现金流出小计110,187,740.04363,215,261.39322,471,527.63310,225,978.98
  筹资活动产生的现金流量净额-110,187,740.04-183,421,461.39-172,677,727.63-170,432,178.98
四、汇率变动对现金及现金等价物的影响-14,104.0943,743.355,411.662,092.36
五、现金及现金等价物净增加额-637,724,785.32343,679,518.33-106,580,730.38-188,500,088.75
  加:期初现金及现金等价物余额1,143,392,808.7799,713,290.37799,713,290.37799,713,290.37
  期末现金及现金等价物余额505,668,023.381,143,392,808.7693,132,559.99611,213,201.62
补充资料:
  净利润-219,897,935.04-114,520,580.49
  资产减值准备-8,089,709.48-13,767,204.48
  固定资产和投资性房地产折旧-72,760,457.82-35,774,633.66
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-72,760,457.82-35,774,633.66
  无形资产摊销-4,008,303.32-1,953,953.39
  长期待摊费用摊销-11,753,812.35-4,368,042.76
  处置固定资产、无形资产和其他长期资产的损失-8,912.45-8,912.45
  固定资产报废损失-121,629.93-34,737.67
  公允价值变动损失-3,572,949.83--1,897,619.2
  财务费用-3,637,284.9-1,981,355.06
  投资损失--5,433,347.58--109,780.81
  递延所得税--4,780,003.24--1,053,860.11
  其中:递延所得税资产减少--4,780,003.24--1,053,860.11
  存货的减少-27,985,503.4--2,385,947.8
  经营性应收项目的减少-64,310,437.57-23,450,282.53
  经营性应付项目的增加--37,732,386.58--125,090,006.85
  现金的期末余额-1,143,392,808.7-611,213,201.62
  减:现金的期初余额-799,713,290.37-799,713,290.37
  现金及现金等价物的净增加额-343,679,518.33--188,500,088.75
公告日期2026-04-212026-04-212025-10-172025-08-26
审计意见(境内)标准无保留意见
TOP↑